BMRN
Biomarin Pharmaceutical Inc
$66.41
+1.11% (+$0.73)
Volume
1.34M
52W High
$70.98
52W Low
$49.26
Market Cap
$11.52B
What to Watch This Quarter
Based on historical dataConsensus EPS
$1.16
Whisper EPS
$1.16
0.3% above consensus
Last Quarter
$0.90
Current Streak
2 Beats
Avg Surprise (4Q)
+3.66%
Next Earnings Report
Reports in 40 days
Price Chart
EPS History: Consensus vs Actual
Last 10 quartersPrice Movement Around Earnings
Q2 2026
Aug 6, 2026
1-Day:
+3.82%
5-Day:
+13.16%
Q2 2026
Aug 3, 2026
1-Day:
+1.21%
Q1 2026
May 5, 2026
1-Day:
+2.55%
Q1 2026
May 4, 2026
1-Day:
-4.00%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $874.6M | +17.0% | 66.3% | 9.1% | -$46.6M |
| Q3'25 | $776.1M | +4.1% | 82.0% | -6.0% | -$30.7M |
| Q2'25 | $825.4M | +15.9% | 81.8% | 33.6% | $240.5M |
| Q1'25 | $745.1M | +14.8% | 79.7% | 30.1% | $185.7M |
| Q4'24 | $747.3M | +15.7% | 81.8% | 21.6% | $124.9M |
| Q3'24 | $745.7M | +28.3% | 74.7% | 15.3% | $106.1M |
| Q2'24 | $712.0M | +19.6% | 81.7% | 16.9% | $107.2M |
| Q1'24 | $648.8M | +8.8% | 80.7% | 13.6% | $88.7M |
Company Information
Symbol
BMRN
Company
Biomarin Pharmaceutical Inc
Market Cap
$11.52B
Next Earnings
Oct 26, 2026